Opko Health Inc Stock News

OPKO Health Inc (NASDAQ: OPK) has announced preliminary topline results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19.  This study builds on increasing medical evidence t

(RTTNews) - OPKO Health Inc. (OPK) announced preliminary positive results from its Phase 2 trial with Rayaldee to treat mild-to-moderate COVID-19. The preliminary data indicated that vitamin D repletion therapy can mitigate the severity of upper respiratory tract infections and accelerate recovery from COVID-19. Rayaldee, after oral

Preliminary data indicate that improving vitamin D status with oral RAYALDEE results in earlier resolution of respiratory symptoms associated with COVID-19 Preliminary data indicate that improving vit

The company's revenue over the past 12 months amounted to about $1.87 billion, an increase of 30.2% compared to 2020. OPKO Health's net debt was about $95.7 million in Q3 2021, down 60.4% from a year

4 penny stocks with bullish price targets & buy ratings from analysts. The post 4 Penny Stocks Analysts Say To Buy Now & Targets Up To 117% appeared first on Penny Stocks to Buy, Picks, News and Infor

4 penny stocks with bullish price targets & buy ratings from analysts. The post 4 Penny Stocks Analysts Say To Buy Now & Targets Up To 117% appeared first on Penny Stocks to Buy, Picks, News and Infor

Check these penny stocks out for your watchlist right now The post Making a List of Penny Stocks to Buy? Check These 3 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Information

Check these penny stocks out for your watchlist right now The post Making a List of Penny Stocks to Buy? Check These 3 Out Right Now appeared first on Penny Stocks to Buy, Picks, News and Information

5 penny stocks to buy for under $5 right now. Are they worth the risk? The post 5 Penny Stocks To Buy For Under $5 This Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyS

5 penny stocks to buy for under $5 right now. Are they worth the risk?

Check these three penny stocks out for your list right now The post Popular Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Check these three penny stocks out for your list right now The post Popular Penny Stocks to Add to Your Watchlist Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennySt

Opko Health found using ticker (OPK) now have 5 analysts covering the stock with the consensus suggesting a rating of ''Strong_Buy''. The target price ranges between 8.5 and 5 with a mean TP of 6.7. With the stocks previous close at 4.08 this is indicating there is a potential upside of 64.2%. The 50 day moving average now sits at 3.95 and the 200 day moving average is 3.91. The market cap for the company is $2,719m. You can visit the company''s website by visiting: https://www.opko.com [stock_market_widget type="chart" symbol="OPK" chart="bar" range="6mo" interval="1d" line-color="rgb(49, 125, 189)"] OPKO Health, a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company''s Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women''s health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services.

Company beats top and bottom line estimates in Q3. NGENLA Somatrogon gets approved for pediatric growth deficiency through Pfizer in Canada.